Download Full Volume - United States Renal Data System

BPREVALENCE OF REPORTED ESRD
Reference section B
Table B.1 B.1 (continued)
Point prevalent counts of of reported ESRD: all patients
patients
patients
alive
alive
on
on
December
December
31
31
of
of
each
each
year,
year,
by
by
demographic
demographic
characteristics
characteristics
& primary
primary
diagnosis
diagnosis
320
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
0-4 394 424 418 420 446 414 430 450 492 495 497 502
5-9 746 777 806 822 842 913 896 918 903 938 952 982
10-14 1,294 1,353 1,457 1,537 1,591 1,586 1,683 1,711 1,799 1,826 1,924 1,902
15-19 2,496 2,598 2,724 2,877 2,964 3,073 3,138 3,268 3,309 3,396 3,473 3,647
20-29 14,716 15,074 15,380 15,624 16,015 16,296 16,620 16,726 16,817 16,847 16,831 16,948
30-39 32,312 34,229 36,123 37,338 38,435 39,233 40,106 40,976 41,721 42,127 42,515 42,832
40-49 40,238 44,246 48,351 52,673 56,557 59,624 63,207 66,264 69,316 71,737 73,998 76,325
50-59 41,332 45,439 50,123 53,972 58,858 64,564 70,767 77,102 83,126 89,328 94,767 100,559
60-64 23,604 25,384 27,419 29,463 31,578 33,786 36,384 38,585 40,793 43,165 46,277 49,560
65-69 25,216 27,479 29,764 31,509 33,749 35,516 37,301 39,231 41,008 42,993 44,813 46,843
70-79 36,476 40,227 45,209 49,131 53,891 58,793 62,866 66,530 69,942 72,239 75,423 77,579
80+ 11,047 12,718 14,501 16,198 18,202 20,335 22,545 24,852 27,714 30,069 32,837 35,277
Unknown * * * * * * * * * * * *
0-19 4,930 5,152 5,405 5,656 5,843 5,986 6,147 6,347 6,503 6,655 6,846 7,033
20-44 67,241 71,167 74,787 77,984 80,952 83,477 86,143 88,380 90,122 91,459 92,428 93,605
45-64 84,961 93,205 102,609 111,086 120,491 130,026 140,941 151,273 161,651 171,745 181,960 192,619
65-74 46,966 51,586 56,680 60,310 64,780 68,950 72,554 75,997 79,423 82,620 85,969 89,105
75+ 25,773 28,838 32,794 36,528 41,062 45,694 50,158 54,616 59,241 62,681 67,104 70,594
Unknown * * * * * * * * * * * *
Male 123,871 134,852 146,834 157,167 169,140 181,135 193,447 205,449 217,217 227,955 239,615 250,523
Female 105,993 115,088 125,436 134,386 143,976 152,985 162,485 171,152 179,710 187,192 194,677 202,400
Unknown 13 12 * 13 14 14 12 13 14 14 16 34
White 147,243 158,626 171,580 181,966 194,293 206,486 218,833 231,476 244,098 255,176 266,451 277,048
Black 72,426 79,577 87,176 93,977 101,167 108,207 115,703 121,844 127,561 132,792 138,624 144,245
Native American 2,798 3,107 3,427 3,752 4,040 4,323 4,710 5,047 5,307 5,591 5,796 5,943
Asian 6,538 7,689 8,851 9,935 10,961 11,992 13,144 14,347 15,551 16,733 17,993 19,129
Other/unknown 872 953 1,246 1,936 2,669 3,126 3,554 3,900 4,424 4,869 5,444 6,592
†Hispanic 31,720 35,417 39,086 42,929 47,126 51,052 55,233 59,608
†Non-Hispanic 281,410 298,717 316,858 333,685 349,815 364,109 379,075 393,349
Diabetes 64,645 72,594 81,832 91,178 101,605 111,989 121,955 130,942 140,532 148,949 157,406 165,113
Hypertension 60,308 65,988 72,260 75,208 79,172 83,197 87,645 92,129 96,268 100,287 104,843 109,642
Glomerulonephritis 46,370 49,419 52,713 55,571 58,599 61,336 64,164 66,706 68,812 70,778 72,771 74,444
Cystic kidney 11,561 12,332 13,165 13,932 14,628 15,335 16,247 17,108 17,968 18,732 19,555 20,409
Other urologic 7,281 7,469 7,817 8,669 9,491 10,241 10,904 11,757 12,338 12,818 13,421 13,861
Other cause 25,468 27,172 28,947 31,067 33,022 34,834 37,024 38,913 40,875 42,477 44,221 46,022
Unknown cause 10,879 11,644 12,383 12,759 13,390 13,960 14,626 15,445 16,264 17,068 17,807 18,656
Missing disease 3,365 3,334 3,163 3,182 3,223 3,242 3,379 3,614 3,884 4,052 4,284 4,810
U.S. 225,716 245,595 267,613 286,830 308,171 329,058 350,651 371,105 391,232 409,298 428,198 446,401
U.S territories 252 275 310 351 404 449 490 548 582 614 674 708
Puerto Rico 2,666 2,858 3,077 3,192 3,397 3,571 3,734 3,878 4,016 4,134 4,304 4,471
Foreign 182 203 230 246 258 269 284 292 304 302 300 286
Unknown 1,061 1,021 1,050 947 900 787 785 791 807 813 832 1,091
All 229,877 249,952 272,280 291,566 313,130 334,134 355,944 376,614 396,941 415,161 434,308 452,957
Total lost-to-followup 6,900 7,596 8,260 9,014 9,691 11,597 13,002 14,239 15,564 17,044 19,230 21,137
All with lost-to-followup 236,777 257,548 280,540 300,580 322,821 345,731 368,946 390,853 412,505 432,205 453,538 474,094
The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.
Age is calculated as of December 31.
†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.
*Values for cells with 10 or fewer patients are suppressed.